Rheumatoid Arthritis: Monitoring Disease With Neutrophil-To-Monocyte Ratio Overview A recent case-control study conducted in Ibb City, Republic of Yemen, focused on identifying effective hematological markers for monitoring disease activity in patients with chronic rheumatoid arthritis (RA). This autoimmune disease is characterized by chronic inflammation. The study explored three novel inflammatory markers: neutrophil-monocyte
Family Practice Medicine
Cefuroxime Prophylaxis For Cataract Postoperative Endophthalmitis
Cefuroxime Prophylaxis For Cataract Postoperative Endophthalmitis In their meta-analysis, the researchers aimed to evaluate the impact of prophylactic intracameral cefuroxime injection on postoperative endophthalmitis in cataract surgery. They conducted a comprehensive review of the literature up to July 2022, which included a total of 1,167,197 participants who underwent cataract surgery. Out
HIV Treatment And Long-Acting Therapy Preferences
HIV Treatment And Long-Acting Therapy Preferences Overview Recent developments in long-acting antiretroviral therapy (LA-ART) offer promising prospects for enhancing HIV treatment by addressing adherence challenges. However, the success of these regimens depends on their acceptance among people living with HIV (PWH). To investigate patient preferences regarding LA-ART options, we conducted a discrete
Idiopathic Parkinson’s Tremors: Treatment Options
Idiopathic Parkinson's Tremors: Treatment Options The study examines the clinical importance of tremors in idiopathic Parkinson's disease (iPD) and the difficulties encountered in their management. It underscores the diversity of iPD patients and the various symptoms they experience, notably tremors, which significantly affect their quality of life. Despite historical efforts to
Ganaxolone Treatment For Refractory Epilepsy
Ganaxolone Treatment For Refractory Epilepsy Overview In a meta-analysis conducted to evaluate the use of ganaxolone for refractory epilepsy, researchers collected data from four randomized controlled trials involving a total of 659 patients. The analysis revealed that ganaxolone significantly improved the reduction in mean seizure frequency by ≥50% when compared to a
Osteoarthritis Unveiled: Advanced Treatments for Joint Pain
Patient Education This article is tailored for patients. Refer your patients to this article for them to learn more about their condition. Osteoarthritis Unveiled: Advanced Treatments for Joint Pain Osteoarthritis is a common form of arthritis that affects joints in the body. While it is incurable, there are various treatment options available
Cabozantinib Therapy In Hepatocellular Carcinoma
Cabozantinib Therapy In Hepatocellular Carcinoma Hepatocellular carcinoma (HCC) is a predominant form of liver cancer, accounting for approximately 90% of cases. Unfortunately, it carries a grim prognosis, with a median survival rate ranging from 6 to 18 months. Historically, sorafenib had been the established first-line therapy for HCC. However, in recent
Obese Children And Related Skin Conditions
Obese Children And Related Skin Conditions The World Health Organization defines overweight and obesity based on the body mass index (BMI), which is calculated as weight (kg) divided by height (m2). When assessing overweight and obesity in children, it's important to consider their age and gender. To do this, percentile curves
Encapsulated Papillary Carcinoma Membrane Characteristics
Encapsulated Papillary Carcinoma Membrane Characteristics Overview This study focused on encapsulated papillary carcinoma (EPC), a type of breast carcinoma characterized by a thick fibrous capsule-like structure surrounding the tumor, often interpreted as a thickened basement membrane (BM). The primary objective was to investigate the geometric properties of the EPC capsule and determine
Ibrutinib Treatment In Waldenström Macroglobulinemia
Ibrutinib Treatment In Waldenström Macroglobulinemia Waldenström macroglobulinemia (WM) is a rare type of non-hogdkins lymphoma driven by the gene mutation MYD88L265P. Ibrutinib, the first approved treatment, is effective but can cause side effects. A study found that 27% of WM patients needed to reduce Ibrutinib doses due to side effects like
